Digital Biotechnologies, Inc. — Form D

Digital Biotechnologies, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-31. The offering totals $15.0M, of which $12.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-12-31
• Form: D
• Accession: 0002103021-25-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $15.0M
• Amount sold: $12.3M
• Remaining: $2.7M
• Investors: 61
• Date of first sale: 2025-12-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-568569

Issuer

• Name: Digital Biotechnologies, Inc.
• CIK: 0002103021
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 1551 Eastlake Avenue East, SEATTLE, WA, 98102
• Phone: (206) 659-0067

Officers, directors & promoters (3)

More

• CIK 2103021 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search